Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 22 | $10,993,139 |
| Sells | 1 | $81,274 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 27 Mar 2025 16:40 | PRLD | Prelude Therapeutics Inc | COMBS ANDREW | Chief Chemistry Officer | 25 Mar 2025 | Purchase | 100,000 | 0.6925 | 69,250 | D |
| 27 Mar 2025 16:37 | PRLD | Prelude Therapeutics Inc | VADDI KRISHNA | CEO | 25 Mar 2025 | Purchase | 675,000 | 0.6925 | 467,438 | D |
| 24 Mar 2025 17:03 | PRLD | Prelude Therapeutics Inc | VADDI KRISHNA | CEO | 20 Mar 2025 | Purchase | 5,416 | 0.7294 | 3,950 | D |
| 24 Mar 2025 17:03 | PRLD | Prelude Therapeutics Inc | VADDI KRISHNA | CEO | 21 Mar 2025 | Purchase | 15,000 | 0.7306 | 10,959 | D |
| 18 Mar 2025 16:27 | PRLD | Prelude Therapeutics Inc | VADDI KRISHNA | CEO | 14 Mar 2025 | Purchase | 29,999 | 0.7544 | 22,631 | D |
| 18 Mar 2025 16:27 | PRLD | Prelude Therapeutics Inc | VADDI KRISHNA | CEO | 17 Mar 2025 | Purchase | 9,106 | 0.7499 | 6,829 | D |
| 14 Mar 2025 08:02 | PRLD | Prelude Therapeutics Inc | VADDI KRISHNA | CEO | 12 Mar 2025 | Purchase | 47,500 | 0.7104 | 33,744 | D |
| 14 Mar 2025 08:02 | PRLD | Prelude Therapeutics Inc | VADDI KRISHNA | CEO | 13 Mar 2025 | Purchase | 50,000 | 0.7164 | 35,820 | D |
| 03 Jan 2025 07:41 | PRLD | Prelude Therapeutics Inc | VADDI KRISHNA | CEO | 31 Dec 2024 | Purchase | 5,000 | 1.2087 | 6,043 | I |
| 02 Jan 2025 16:09 | PRLD | Prelude Therapeutics Inc | VADDI KRISHNA | CEO | 30 Dec 2024 | Purchase | 10,000 | 1.2 | 12,000 | I |
| 26 Dec 2024 07:49 | PRLD | Prelude Therapeutics Inc | COMBS ANDREW | Chief Chemistry Officer | 20 Dec 2024 | Purchase | 3,075 | 1.15 | 3,536 | D |
| 26 Dec 2024 07:49 | PRLD | Prelude Therapeutics Inc | COMBS ANDREW | Chief Chemistry Officer | 23 Dec 2024 | Purchase | 60,000 | 1.3667 | 82,002 | D |
| 20 Dec 2024 07:35 | PRLD | Prelude Therapeutics Inc | LIM BRYANT DAVID | CLO, Interim CFO, Corp Sec. | 19 Dec 2024 | Purchase | 25,000 | 0.9055 | 22,638 | D |
| 20 Dec 2024 07:33 | PRLD | Prelude Therapeutics Inc | VADDI KRISHNA | CEO | 18 Dec 2024 | Purchase | 100,000 | 0.9321 | 93,210 | D |
| 20 Dec 2024 07:33 | PRLD | Prelude Therapeutics Inc | VADDI KRISHNA | CEO | 19 Dec 2024 | Purchase | 6,888 | 0.8879 | 6,116 | I |
| 26 May 2023 16:20 | PRLD | Prelude Therapeutics Inc | VADDI KRISHNA | CEO | 25 May 2023 | Purchase | 900 | 5.31 | 4,779 | D |
| 26 May 2023 16:20 | PRLD | Prelude Therapeutics Inc | VADDI KRISHNA | CEO | 24 May 2023 | Purchase | 1,000 | 5.0114 | 5,011 | D |
| 25 May 2023 16:07 | PRLD | Prelude Therapeutics Inc | LIM BRYANT DAVID | Chief Legal Officer, Corp Sec. | 24 May 2023 | Purchase | 2,400 | 5.39 | 12,936 | D |
| 25 May 2023 16:05 | PRLD | Prelude Therapeutics Inc | CHARDONNET LAURENT | Chief Financial Officer | 23 May 2023 | Purchase | 5,000 | 5.5 | 27,500 | D |
| 25 May 2023 16:03 | PRLD | Prelude Therapeutics Inc | VADDI KRISHNA | CEO | 23 May 2023 | Purchase | 11,856 | 5.63 | 66,749 | D |
| 24 May 2023 17:09 | PRLD | Prelude Therapeutics Inc | ORBIMED ADVISORS LLC | Director , 10% | 22 May 2023 | Purchase | 869,565 | 5.75 | 4,999,999 | I |
| 24 May 2023 17:07 | PRLD | Prelude Therapeutics Inc | BONITA DAVID P | Director , 10% | 22 May 2023 | Purchase | 869,565 | 5.75 | 4,999,999 | I |
| 06 Apr 2023 18:19 | PRLD | Prelude Therapeutics Inc | HUANG JANE | President, CMO | 06 Apr 2023 | Sale | 13,280 | 6.12 | 81,274 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)